Albert Benjamin 4
4 · Health Catalyst, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Health Catalyst CEO Albert Benjamin Sells 336 Shares
What Happened Albert Benjamin, CEO and Director of Health Catalyst, disposed of 336 shares on 2026-06-01 at $1.37 per share for proceeds reported as $460. This was a sale required to cover tax withholding tied to the vesting of restricted stock units, not a discretionary open-market sale.
Key Details
- Transaction date & price: 2026-06-01 at $1.37 per share (336 shares, ~$460 proceeds).
- Shares owned after transaction: Not stated in the provided filing.
- Footnote: The sale was a mandatory "sell-to-cover" to satisfy tax withholding on RSU vesting (see F1). This does not reflect a voluntary trade decision by the insider.
- Filing timeliness: Report filed 2026-06-03 for a 2026-06-01 transaction — appears to be filed within the typical two-business-day Form 4 window.
Context Sell-to-cover transactions are routine administrative actions when equity awards vest; they generally do not signal insider sentiment about the company. For investors, purchases are typically more informative than mandatory sales for tax withholding.
Insider Transaction Report
Form 4
Albert Benjamin
DirectorCEO
Transactions
- Tax Payment
Common Stock
[F1]2026-06-01$1.37/sh−336$460→ 1,458,456 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Signature
/s/ Benjamin Landry, as Attorney-in-Fact|2026-06-03